Literature DB >> 19714293

Bilateral facial nerve enhancement demonstrated by magnetic resonance imaging in Guillain-Barré syndrome.

Nilgul Yardimci1, Aynur Yilmaz Avci, Esra Kayhan, Sibel Benli.   

Abstract

Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating peripheral nerve disorder. It is known that gadolinium enhancement on magnetic resonance imaging (MRI) reflects alteration of the blood-nerve barrier secondary to inflammation. Enhancement of the cauda equina roots with gadolinium on lumbosacral magnetic resonance imaging have been demonstrated in several reports. Although about 50% of GBS patients clinically exhibit facial nerve involvement, it has never been demonstrated on MRI. We aimed to observe facial nerve involvement in a GBS patient who has prominent facial diplegia. With the guidance of the literature, we predict that MRI in selected GBS patients may be an adjunct tool for the clinician in both diagnosis and monitoring the treatment response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19714293     DOI: 10.1007/s10072-009-0120-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

2.  Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy.

Authors:  G W Morgan; R J Barohn; C Bazan; R B King; R P Klucznik
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

Review 3.  Pathogenesis of Guillain-Barré syndrome.

Authors:  R A Hughes; R D Hadden; N A Gregson; K J Smith
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

4.  Magnetic resonance imaging of the cauda equina in Guillain-Barré syndrome.

Authors:  P B Crino; R Zimmerman; D Laskowitz; E C Raps; A M Rostami
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

5.  Magnetic resonance imaging of nerve root inflammation in the Guillain-Barré syndrome.

Authors:  J R Perry; A Fung; P Poon; N Bayer
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

6.  Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome.

Authors:  K C Gorson; A H Ropper; M A Muriello; R Blair
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

7.  Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome.

Authors:  R Pedotti; M Carpo; S Lucchi; A Righini; G Scarlato; E Nobile-Orazio
Journal:  J Neurol       Date:  1998-11       Impact factor: 4.849

  7 in total
  6 in total

1.  Guillain-Barré syndrome variant with prominent facial diplegia, limb paresthesia, and brisk reflexes.

Authors:  Helmar C Lehmann; Stephan Macht; Sebastian Jander; Hans-Peter Hartung; Axel Methner
Journal:  J Neurol       Date:  2011-07-19       Impact factor: 4.849

2.  Magnetic resonance imaging findings in Guillain-Barré syndrome caused by Zika virus infection.

Authors:  Cristina Asvolinsque Pantaleão Fontes; Alair Augusto S M Damas Dos Santos; Edson Marchiori
Journal:  Neuroradiology       Date:  2016-04-11       Impact factor: 2.804

3.  Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement.

Authors:  G Zuccoli; A Panigrahy; A Bailey; C Fitz
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

4.  Case Report and Literature Analysis: Guillain-Barré Syndrome With Delayed Unilateral Facial Palsy.

Authors:  Xuanyu Huang; Ziwei Lan; Yajing Zhan; Zhiping Hu
Journal:  Front Neurol       Date:  2021-03-31       Impact factor: 4.003

5.  Guillain-barre syndrome presenting with bilateral facial nerve palsy.

Authors:  Sorour Inaloo; Pegah Katibeh
Journal:  Iran J Child Neurol       Date:  2014

6.  Guillain-Barré Syndrome: A Variant Consisting of Facial Diplegia and Paresthesia with Left Facial Hemiplegia Associated with Antibodies to Galactocerebroside and Phosphatidic Acid.

Authors:  Sho Nishiguchi; Joel Branch; Tsubasa Tsuchiya; Ryoji Ito; Junya Kawada
Journal:  Am J Case Rep       Date:  2017-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.